Fanconi’s syndrome induced by a monoclonal Vκ3 light chain in Waldenström’s macroglobulinemia
Frank Bridoux(Université de Poitiers), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Nathalie Quellard(Université de Poitiers), R. Abou-Ayache(Université de Poitiers), Michel Cogné(Centre National de la Recherche Scientifique), Christophe Sirac(Centre National de la Recherche Scientifique), Antoine Thierry(Université de Poitiers), Catherine Decourt(Centre National de la Recherche Scientifique), Jean‐Michel Goujon(Centre Hospitalier Universitaire de Poitiers), Valérie Hugue(Centre National de la Recherche Scientifique)
Cited by 62
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520